Global Finance Changes
0
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes > Investing > Completion of preclinical data package for RAD 402
Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0 Shares
Share on Facebook Share on Twitter Share on Pinterest Share on Email
admin December 10, 2024
Previous Article Equities Remain in Strong “Go” Trend as Tech Returns to Leadership
Next Article Capital Raising and QSM Completion Update

You Might Also Enjoy

Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development

May 13, 2025
READ MORE

Nuvau Minerals Completes High Resolution Drone MAG Survey

May 13, 2025
READ MORE

Heaven’s Earthly Treasures: Behind the Metallurgy of the Papal Symbols

May 13, 2025
READ MORE

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee

May 13, 2025
READ MORE
  • Privacy Policy
  • Terms & Conditions

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.


    • Privacy Policy
    • Terms & Conditions
    Copyright © 2025 globalfinancechanges.com | All Rights Reserved

    Our website uses cookies to improve your experience. Learn more about: Cookie Policy

    Accept